DiscoverNP Pulse: The Voice of the Nurse Practitioner (AANP)46. Biosimilars: Changing the Treatment Landscape for Inflammatory Conditions
46. Biosimilars: Changing the Treatment Landscape for Inflammatory Conditions

46. Biosimilars: Changing the Treatment Landscape for Inflammatory Conditions

Update: 2022-01-26
Share

Description

NPs Lisa Kennedy Sheldon and Sharon Dudley Brown discuss how biosimilars can enrich treatment options for patients with inflammatory diseases, such as RA, psoriatic arthritis, ankylosing spondylitis, Crohn's disease and more.


 


Resources from this episode:



 


Join AANP Today: join.aanp.org

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

46. Biosimilars: Changing the Treatment Landscape for Inflammatory Conditions

46. Biosimilars: Changing the Treatment Landscape for Inflammatory Conditions

American Association of Nurse Practitioners (AANP)